R ecent work has suggested that thrombophilia may be an aetiological factor in up to 50% of children with Perthes' disease, and that up to 75% may have a coagulopathy. Our aim was to test these findings in the local population of children with Perthes' disease and attempt to correlate them with the severity of the condition.
Perthes' disease is a condition involving the femoral capital epiphysis of children in which one or more infarctions may result in a variable amount of damage to the femoral head. The incidence in the population is variably quoted as 1 in 1200 to 1 in 12 000. 1, 2 In South-East Wales it appears to be very common, occurring in approximately one child in 1500 between the ages of four and eight years, and in approximately 1 in 1100 boys in this age group. Furthermore, it appears to be much more aggressive than in other areas of the UK, with Catterall group I being relatively rare, and accounting for less than 10% of the cases. Perthes' disease is commoner in boys between the ages of four and eight years of age who come from families showing some skeletal dysplasia in their lower limbs, and are in the lower two social classes. 2, 3 The cause of the disease remains obscure. Most would agree that any condition which tends to increase the coagulability of blood is likely to be associated with an increased risk of bone infarction and, perhaps, of necrosis of the head of the femur. Until recently, no evidence has been found for the presence of such a condition in Perthes' disease. In 1996, Glueck et al 4 reported a series of 46 patients with the condition of whom 75% had a demonstrable coagulopathy. In just over 50% of these children it was due to thrombophilia (low plasma levels of protein C or protein S). They estimated that the odds for protein-C thrombophilia and Perthes' disease occurring together by chance are 1 in 325 000. If these findings can be shown to be representative of Perthes' disease in general, then they could indicate an important breakthrough with far-reaching implications for treatment and prophylaxis. The study by Glueck et al 4 was interesting from a haematological point of view, but they made no attempt to correlate their findings with either the severity of the disease or the outcome.
We have therefore analysed a series of children with Perthes' disease to test the reliability of these findings and to see whether abnormalities of the blood were related to the severity of the disease.
Patients and Methods
Between 1989 and 1997, 92 children with Perthes' disease were treated at the Royal Gwent Hospital by one of the authors (KT). Of these, 64 were entered into the study; the remainder could not be traced. There were 48 boys and 16 girls, giving a ratio of 3 to 1. The mean age of the children at diagnosis was 6.7 years (2.8 to 9), and when assessed by blood testing 9.3 years (3 to 15.2). Of the 64 children, 44 were from families of social classes 4 and 5 (69%).
When first seen all patients were assessed clinically and radiologically using anteroposterior and lateral radiographs of the hips. A Catterall group 5 was assigned to the affected hips and appropriate treatment begun. Regular follow-up was carried out until radiological healing was seen. The patients were then asked to attend a special clinic where they were examined and, with parental consent, a blood clotting screen was carried out to measure, among other things, the plasma levels of protein C, free protein S, antithrombin III (AT III) and modified activated protein C resistance (APCR; modified to take account of factor V Leiden).
A test was judged to be low and require checking if it fell below the normal adult range. The ranges of our laboratory were 70% to 120% for protein C functional, 50% to 130% for free protein S antigen, 80% to 120% for AT III functional and >2 for APCR. The first three figures are expressed as the percentage of the concentration found in pooled plasma. Active protein C was determined by a chromogenic assay (Instrumentation Laboratory, Warrington, UK), protein S antigen by Laurell Rocket immunoelectrophoresis (Sigma Laboratories, Gillingham, UK), active AT III function by a chromogenic assay (Instrumentation Laboratory), and APCR using Diagen instrumentation (Diagen, Thame, UK).
It has been shown by Andrew et al 6 that the levels of various coagulation proteins in children are lower than those in adults. Nevertheless, adult levels are appropriate when comparing the altered balance of procoagulants and anticoagulants which occurs in children, provided that, when carrying out research, care is taken not to interpret 'low' levels as a genuine deficiency. The definitive normal ranges used in our study for analysing the data are those established by Andrew et al 6 in 1992 for the age range of six to ten years.
All the children attended with at least one parent and details regarding any family history of thrombotic diseases in first-degree relatives were taken. These included myocardial infarctions, deep-vein thrombosis and cerebrovascular accidents.
Comprehensive sets of radiographs were available for each child from their initial presentation with the Catterall group assigned by one of the authors at this time. All of these were reviewed by another of the authors (PT) and two independent radiologists to eliminate the problems highlighted by Hardcastle et al 7 regarding the difficulties with the Catterall grading.
Results
Compared with adults, 18 children had low blood concentrations (Table I) , but when using the paediatric values of Andrew et al, 6 only eight had genuinely low results; all had normal protein C levels, but one child had a low protein S level, three a low AT III level and four a low APCR value (Table II) . The three low AT III levels were not far below normal. Thus, five (7.8%) of these children showed thrombophilic tendencies (low protein S and APCR) and a further three (4.6%) with slightly low AT III levels may have had a reduced capacity to limit clot development.
In order to emphasise how normal most of our cases were, the results are illustrated in Figures 1 to 4 . The relationship of haematological findings to Catterall groups. The general distribution of our patients into Catterall groups is shown in Figure 5 . Because of the unexpectedly small number of children with abnormal blood results, no statistically valid relationship could be drawn between them and the severity of the Perthes' disease.
The eight children with low blood concentrations presented with a variety of Catterall groups as shown in Table  II . It can be seen that the single patient with free protein S deficiency was in group III, as were all three with low AT III. The four with low APCR were spread generally, with one in group I, two in group II and one in group IV. Graph to show the distribution of protein C levels with age in the whole series. Concentrations for patients shown below the horizontal line were considered low compared with paediatric values. Fig. 2 Graph to show the distribution of protein S levels with age in the whole series. Concentrations for patients shown below the horizontal line were considered low compared with paediatric values. Fig. 3 Graph to show the distribution of AT III levels with age in the whole series. Concentrations for patients shown below the horizontal line were considered low compared with paediatric values.
Incidence of thrombotic disorders in first-degree relatives. No coagulation screens were carried out on firstdegree relatives, but none of the relatives of the eight children with low blood concentrations had an increased incidence of thrombotic-related disorders.
Discussion
The aetiology of Perthes' disease has been much debated with only vague clues as to the mechanism until the recent work of Glueck et al 4 which suggested that a congenital deficiency of certain plasma proteins affecting clot limitation may be relevant. Although carefully analysed, they did not correlate their findings with the severity of Perthes' disease. One of the objects of our study was to investigate this aspect.
Our patients were of similar age, gender and social class to those in other published series, including those of Glueck et al 4 and hence can be considered to be a representative sample of children with the disorder. However, there were fewer mild cases (Catterall group I). Our results showed low values of various clotting proteins in about 25% of the children when compared with adults, but only 12% were genuinely low when measured against established normal paediatric values. Only about 8% showed any thrombophilic tendencies. These findings differ markedly from the 75% and 50% found in the series reported from Cincinnati by Glueck et al. 4 It may be that this can be explained by a difference in ethnic mix or that the samples are relatively small. An important question is whether the 12% with low blood tests in our series are indeed abnormal. In 1986, Karpatkin et al 8 showed that infants had low plasma levels of protein C, but there was little else published to suggest that childhood levels of other blood proteins differed from those in the adult, until the work of Andrew et al. 6 In a large series of almost 300 children, they showed that between the ages of one and 16 years 25% had low serum protein C levels and 15% low serum protein S levels when compared with adults. They then calculated the normal ranges for children in different age groups and showed immature levels of various blood-clotting proteins, which rise with advancing age. Thus, it seems likely that several, if not all of the eight abnormal cases found in our study, are physiological rather than pathological variations. To prove this point beyond reasonable doubt it would be necessary to test a very large number of normal children to act as a control group. This was deemed unethical since the normal ranges have already been established 6 and most of our cases fell within these. In their study, Glueck et al 4 used a control group of 30 children. This may not be a large enough sample on which to establish normal values when they are being related to large populations and the normal range is wide, varying with age. A further criticism, of both the study by Glueck et al 4 and our own, is that the patients were all tested some time Graph to show the distribution of modified APCR levels with age in the whole series. Concentrations for patients shown below the horizontal line were considered low compared with paediatric values.
Fig. 5
Diagram to illustrate the distribution of the Catterall groups in the whole series.
after the onset of Perthes' disease. This could question the relevance of any findings, particularly with regard to levels of protein C and protein S which are known to rise during childhood. However, if Perthes' disease is related to congenital thrombophilia, this should always be apparent regardless of age, as the study by Glueck et al 4 tries to suggest. A further hypothesis that Perthes' disease may in some way be related to the normal physiological low levels of protein C found in very young children can also be discounted, since this would require the disease to be common in toddlers, which it is not. If the cause of Perthes' disease is related to an inherited risk of thrombotic episodes, then an increased incidence of such problems would be expected in the near relatives. Although thrombophilia predisposes patients to an increased incidence of venous thrombosis, we did not find any evidence of this or other thrombotic disease in near relatives of the group which we studied. This is particularly interesting when it is remembered that there is a very high incidence of coronary artery disease in the population of South Wales, and therefore the chance of linking a family history of thrombotic problems to almost any condition found in this area is a very real possibility. Despite this, no link could be shown.
In children in South Wales we can find no convincing evidence that there is any relationship between most cases of Perthes' disease in children and any increased liability to thrombosis.
